Antrin brand of motexafin lutetium

Known as: Antrin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-2002
0119892002

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
BACKGROUND Motexafin lutetium (MLu; Antrin) is a photosensitizer that is taken up by atherosclerotic plaque and concentrated… (More)
  • figure 1
  • table 1
  • table 3
  • table 2
  • figure 2
Is this relevant?
Review
2002
Review
2002
Photodynamic therapy (PDT) has been approved as a tissue-specific light-activated cytotoxic therapy for many diseases. The… (More)
Is this relevant?
2001
2001
OBJECTIVE Motexafin lutetium (Lu-Tex, Antrin Injection) is a photosensitizer that selectively accumulates in atheromatous plaque… (More)
  • table 1
  • figure 2
  • figure 4
Is this relevant?
2001
2001
Pharmacyclics is developing the photosensitizer, motexafin lutetium as Antrin for the potential treatment of restenosis and… (More)
Is this relevant?
Review
2000
Review
2000
The texaphyrins are quintessential metal-coordinating expanded porphyrins. They constitute a new series of synthetic porphyrin… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1993
1993
Mammalian prosomatostatin (PSS) is cleaved at a dibasic Arg-Lys site to produce somatostatin-14 (SS-14) and at monobasic Arg and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
1990
1990
Mammalian prosomatostatin (pro-S) undergoes extensive processing at the C-terminal segment where the somatostatin-like biological… (More)
Is this relevant?
Review
1990
Review
1990
Several peptides are generated from prosomatostatin (proSS) in addition to somatostatin-14 (SS-14) and somatostatin-28 (SS-28… (More)
Is this relevant?
1989
1989
The three widely distributed peptides derived from prosomatostatin are the original neurohormone somatostatin-14, somatostatin-28… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?